ClinicalTrials.Veeva

Find clinical trials for Endometrial Cancer in Detroit, MI

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Ovarian Cancer
Breast Cancer
Triple Negative Breast Cancer
Ovarian Epithelial Carcinoma
Lung Cancer

Endometrial Cancer trials near Detroit, MI, USA:

Abemaciclib and Letrozole to Treat Endometrial Cancer

letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...

Active, not recruiting
Endometrial Cancer
Drug: Abemaciclib
Drug: Letrozole

Phase 2

Gynecologic Oncology Group (GOG)

Ann Arbor, Michigan, United States and 28 other locations

This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...

Enrolling
Endometrial Cancer
Drug: INCAGN02390
Drug: pemigatinib

Phase 2

Incyte
Incyte

Detroit, Michigan, United States and 66 other locations

participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....

Active, not recruiting
Neoplasms
Drug: Carboplatin
Drug: Paclitaxel

Phase 3

Tesaro
Tesaro

Detroit, Michigan, United States and 162 other locations

This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of vudalimab (XmAb20717) in...

Enrolling
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Endometrial Cancer
Biological: vudalimab

Phase 2

Xencor
Xencor

Detroit, Michigan, United States and 11 other locations

in participants with solid tumors.Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be remov...

Enrolling
Endometrial Cancer
Hormone Receptor-positive Breast Cancer
Drug: PRO1184

Phase 1, Phase 2

ProfoundBio

Detroit, Michigan, United States and 15 other locations

The goal of this clinical trial is to evaluate the safety of TOS-358 in adults with select solid tumors who meet study enrollment criteria. The main...

Enrolling
Endometrial Cancer
Gastric Cancer
Drug: TOS-358

Phase 1

Totus Medicines

Detroit, Michigan, United States and 11 other locations

+ breast cancer, epithelial ovarian cancer, endometrial cancer, cutaneous melanoma, thyroid cancer, SCLC...

Enrolling
Endometrial Cancer
Small-cell Lung Cancer
Drug: TH1902

Phase 1

Theratechnologies

Detroit, Michigan, United States and 5 other locations

to other places in the body, it is called advanced or metastatic cancer. Participants in this study must have head and neck squamous cell ca ...

Enrolling
Endometrial Neoplasms
Ovarian Neoplasms
Drug: disitamab vedotin

Phase 2

Seagen
Seagen

Detroit, Michigan, United States and 22 other locations

However, the preferred tumor types for enrollment are colorectal cancer (CRC), non-small cell lung cancer (NSCLC), squamous cell ca ...

Enrolling
Endometrial Cancer
Non Small Cell Lung Cancer
Drug: TPST-1495 once daily or on intermittent schedule
Drug: Pembrolizumab

Phase 1

Tempest Therapeutics

Ann Arbor, Michigan, United States and 10 other locations

in participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSigna...

Enrolling
Endometrial Adenocarcinoma
Platinum-resistant Ovarian Cancer
Drug: ACR-368
Diagnostic Test: OncoSignature

Phase 1, Phase 2

Acrivon Therapeutics

Detroit, Michigan, United States and 66 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems